National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Aceruloplasminemia



Other Names:
Ceruloplasmin deficiency; Familial apoceruloplasmin deficiency; Hereditary ceruloplasmin deficiency; Ceruloplasmin deficiency; Familial apoceruloplasmin deficiency; Hereditary ceruloplasmin deficiency; Hypoceruloplasminemia; Systemic hemosiderosis due to aceruloplasminemia See More
Categories:
This disease is grouped under:

Aceruloplasminemia is a disorder of iron metabolism.[1] This disorder causes iron to build-up in the body. Signs and symptoms begin in adulthood. People with this disorder tend to develop anemia and diabetes in their 20's.[2] As the condition progresses, movement problems are common, such as tremors, choreaataxia, eyelid twitching, and grimacing.[2] Some experience psychiatric problems and dementia in their 40's and 50's.[2] Eye examination may reveal changes in the retina, but these changes typically do not affect vision.[2] Aceruloplasminemia is caused by mutations in the CP gene and are inherited in an autosomal recessive fashion.[2]
Last updated: 8/3/2011

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 28 |
Medical Terms Other Names
Learn More:
HPO ID
80%-99% of people have these symptoms
Chorea 0002072
Decreased serum ceruloplasmin 0010837
Diabetes mellitus 0000819
Elevated hepatic iron concentration
Increased iron concentration in liver
0012465
Increased serum ferritin
Elevated serum ferritin
High ferritin level
Increased ferritin
Increased serum ferritin level
[ more ]
0003281
Refractory anemia 0005505
Retinal degeneration
Retina degeneration
0000546
Tremor 0001337
30%-79% of people have these symptoms
Ataxia 0001251
Blepharospasm
Eyelid spasm
Eyelid twitching
Involuntary closure of eyelid
Spontaneous closure of eyelid
[ more ]
0000643
Delayed speech and language development
Deficiency of speech development
Delayed language development
Delayed speech
Delayed speech acquisition
Delayed speech development
Impaired speech and language development
Impaired speech development
Language delay
Language delayed
Language development deficit
Late-onset speech development
Poor language development
Speech and language delay
Speech and language difficulties
Speech delay
[ more ]
0000750
Dementia
Dementia, progressive
Progressive dementia
[ more ]
0000726
Depressivity
Depression
0000716
Hypertonia 0001276
Parkinsonism 0001300
Torticollis
Wry neck
0000473
5%-29% of people have these symptoms
Congestive heart failure
Cardiac failure
Cardiac failures
Heart failure
[ more ]
0001635
Dysarthria
Difficulty articulating speech
0001260
Hypothyroidism
Underactive thyroid
0000821
Memory impairment
Forgetfulness
Memory loss
Memory problems
Poor memory
[ more ]
0002354
Percent of people who have these symptoms is not available through HPO
Abnormality of extrapyramidal motor function 0002071
Aceruloplasminemia 0025498
Adult onset
Symptoms begin in adulthood
0003581
Anemia
Low number of red blood cells or hemoglobin
0001903
Autosomal recessive inheritance 0000007
Cogwheel rigidity 0002396
Decreased serum iron 0040303
Scanning speech
Explosive speech
0002168
Showing of 28 |
Last updated: 7/1/2020

When a person has more than one of the following symptoms, aceruloplasminemia should be suspected:

Diabetes mellitus
Retinal degeneration
Anemia
Movement disorder

Diagnosis can be further supported by MRI and pathology results demonstrating iron deposition in the body. People with aceruloplasminemia tend to have low serum copper (<10 ug/dL), low serum iron (< 45 ug/dL), high serum ferritin (850-4000 ng/mL) and absent serum ceruloplasmin concentration. Patients also tend to demonstrate altered serum ceruloplasmin ferroxidase activity.[1] Genetic testing is available on a research basis.[1]

Last updated: 8/3/2011

If you need medical advice, you can look for doctors or other healthcare professionals who have experience with this disease. You may find these specialists through advocacy organizations, clinical trials, or articles published in medical journals. You may also want to contact a university or tertiary medical center in your area, because these centers tend to see more complex cases and have the latest technology and treatments.

If you can’t find a specialist in your local area, try contacting national or international specialists. They may be able to refer you to someone they know through conferences or research efforts. Some specialists may be willing to consult with you or your local doctors over the phone or by email if you can't travel to them for care.

You can find more tips in our guide, How to Find a Disease Specialist. We also encourage you to explore the rest of this page to find resources that can help you find specialists.

Healthcare Resources


Related diseases are conditions that have similar signs and symptoms. A health care provider may consider these conditions in the table below when making a diagnosis. Please note that the table may not include all the possible conditions related to this disease.

Conditions with similar signs and symptoms from Orphanet
Differential diagnoses include other forms of later-onset, slowly progressing NBIA including atypical pantothenate kinase-associated neurodegeneration (PKAN) and neuroferritinopathy, hereditary hemochromatosis, Wilson disease, Huntington disease, dentatorubral pallidoluysian atrophy (DRPLA), juvenile Parkinson disease, hereditary spinocerebellar ataxias (see these terms) and drug effects or toxicity.
Visit the Orphanet disease page for more information.

Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.

Organizations Supporting this Disease


These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

Where to Start

In-Depth Information

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.
  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Aceruloplasminemia. Click on the link to view a sample search on this topic.

News

Other Conferences


Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.


  1. Miyajima H. Aceruloplasminemia. GeneReview. 2003; http://www.ncbi.nlm.nih.gov/books/NBK1493. Accessed 8/3/2011.
  2. Aceruloplasminemia. Genetics Home Reference. 2008; http://ghr.nlm.nih.gov/condition=aceruloplasminemia. Accessed 8/3/2011.